The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction-Reference-Cited by-同舟云学术

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Published:2019-08 Issue:5 Volume:15 Page:403-410
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Paitazoglou Christina,Özdemir Ramazan,Pfister Roman,Bergmann Martin W.,Bartunek Jozef,Kilic Teoman,Lauten Alexander,Schmeisser Alexander,Zoghi Mehdi,Anker Stefan,Sievert Horst,Mahfoud Felix

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials;American Heart Journal;2024-09

2. Pulmonale Hypertonie bei Erwachsenen mit angeborenen Herzfehlern im Lichte der 2022-ESC-PAH-Leitlinien;Pneumologie;2024-05-24

3. The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment;Cardiac Failure Review;2024-04-03

4. Left atrial to coronary sinus shunting for treatment of heart failure with mildly reduced or preserved ejection fraction: The ALT FLOW Early Feasibility Study 1‐year results;European Journal of Heart Failure;2024-04

5. Initiation and Up-titration of Guideline-directed Medical Therapy for Patients with Heart Failure: Better, Faster, Stronger!;Cardiac Failure Review;2024-03-06